Skip to main content

Congenital Hepatic Vascular Malformations

  • Chapter
  • First Online:
Vascular Liver Disease
  • 1507 Accesses

Abstract

Congenital hepatic vascular malformations are rare entities that result in abnormal shunting of blood through the liver. Three different types of shunting can occur: arteriovenous (hepatic artery to hepatic vein), arterioportal (hepatic artery to portal vein) and portovenous (portal vein to hepatic vein). Malformations result from alterations in the formation of blood vessels during fetal development and can occur as an isolated abnormality or form a part of a systemic illness, such as hereditary hemorrhagic telangiectasia in which all three types of shunting coexist. Clinical features depend on the type and extent of shunting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gallego C, Miralles M, Marin C, Muyor P, Gonzalez G, Garcia-Hidalgo E. Congenital hepatic shunts. Radiographics 2004; 24(3):755–772.

    Article  PubMed  Google Scholar 

  2. Khalid SK, Garcia-Tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Sem Liv Dis 28, 247–258. 2008.Ref Type: Abstract

    Google Scholar 

  3. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol 2007; 46(3):499–507.

    Article  PubMed  CAS  Google Scholar 

  4. Boon LM, Burrows PE, Paltiel HJ, Lund DP, Ezekowitz RA, Folkman J et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129(3):346–354.

    Article  PubMed  CAS  Google Scholar 

  5. Prokurat A, Kluge P, Chrupek M, Kosciesza A, Rajszys P. Hemangioma of the liver in children: proliferating vascular tumor or congenital vascular malformation? Med Pediatr Oncol 2002; 39(5):524–529.

    Article  PubMed  Google Scholar 

  6. Alexander CP, Sood BG, Zilberman MV, Becker C, Bedard MP. Congenital hepatic arteriovenous malformation: an unusual cause of neonatal persistent pulmonary hypertension. J Perinatol 2006; 26(5):316–318.

    Article  PubMed  CAS  Google Scholar 

  7. Botha T, Rasmussen O, Carlan SJ, Greenbaum L. Congenital hepatic arteriovenous malformation: sonographic findings and clinical implications. Journal of Diagnostic Medical Sonography 2004; 20(17):177–181.

    Article  Google Scholar 

  8. Vauthey JN, Tomczak RJ, Helmberger T, Gertsch P, Forsmark C, Caridi J et al. The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology 1997; 113(4):1390–1401.

    Article  PubMed  CAS  Google Scholar 

  9. Gallego C, Velasco M, Marcuello P, Tejedor D, De Campo L, Friera A. Congenital and acquired anomalies of the portal venous system. Radiographics 2002; 22(1):141–159.

    PubMed  Google Scholar 

  10. Norton SP, Jacobson K, Moroz SP, Culham G, Ng V, Turner J et al. The congenital intrahepatic arterioportal fistula syndrome: elucidation and proposed classification. J Pediatr Gastroenterol Nutr 2006; 43(2):248–255.

    Article  PubMed  Google Scholar 

  11. Kumar N, de GJ, V, Sharif K, McKiernan P, John P. Congenital, solitary, large, intrahepatic arterioportal fistula in a child: management and review of the literature. Pediatr Radiol 2003; 33(1):20–23.

    Article  PubMed  Google Scholar 

  12. Mallant MP, van den Berg FG, Verbeke JI, Bokenkamp A. Pulsatile hepatofugal flow in the portal vein: hallmark of a congenital hepatoportal arteriovenous fistula. J Pediatr Gastroenterol Nutr 2007; 44(1):143–145.

    Article  PubMed  CAS  Google Scholar 

  13. Witters P, Maleux G, George C, Delcroix M, Hoffman I, Gewillig M et al. Congenital veno-venous malformations of the liver: widely variable clinical presentations. J Gastroenterol Hepatol 2008; 23(8 Pt 2):e390-e394.

    Article  PubMed  Google Scholar 

  14. Stringer MD. The clinical anatomy of congenital portosystemic venous shunts. Clin Anat 2008; 21(2):147–157.

    Article  PubMed  Google Scholar 

  15. Morgan G, Superina R. Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies. J Pediatr Surg 1994; 29(9):1239–1241.

    Article  PubMed  CAS  Google Scholar 

  16. Murray CP, Yoo SJ, Babyn PS. Congenital extrahepatic portosystemic shunts. Pediatr Radiol 2003; 33(9):614–620.

    Article  PubMed  Google Scholar 

  17. Park JH, Cha SH, Han JK, Han MC. Intrahepatic portosystemic venous shunt. AJR Am J Roentgenol 1990; 155(3):527–528.

    PubMed  CAS  Google Scholar 

  18. Ortiz M, Cordoba J, Alonso J, Rovira A, Quiroga S, Jacas C et al. Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. J Hepatol 2004; 40(3):552–557.

    Article  PubMed  CAS  Google Scholar 

  19. Wojcicki M, Haagsma EB, Gouw AS, Slooff MJ, Porte RJ. Orthotopic liver transplantation for portosystemic encephalopathy in an adult with congenital absence of the portal vein. Liver Transpl 2004; 10(9):1203–1207.

    Article  PubMed  Google Scholar 

  20. Akahoshi T, Nishizaki T, Wakasugi K, Mastuzaka T, Kume K, Yamamoto I et al. Portal-systemic encephalopathy due to a congenital extrahepatic portosystemic shunt: three cases and literature review. Hepato­gastroenterology 2000; 47(34):1113–1116.

    PubMed  CAS  Google Scholar 

  21. Uchino T, Endo F, Ikeda S, Shiraki K, Sera Y, Matsuda I. Three brothers with progressive hepatic dysfunction and severe hepatic steatosis due to a patent ductus venosus. Gastroenterology 1996; 110(6):1964–1968.

    Article  PubMed  CAS  Google Scholar 

  22. da Rocha AJ, Braga FT, da Silva CJ, Maia AC, Jr., Mourao GS, Gagliardi RJ. Reversal of parkinsonism and portosystemic encephalopathy following embolization of a congenital intrahepatic venous shunt: brain MR imaging and 1H spectroscopic findings. AJNR Am J Neuroradiol 2004; 25(7):1247–1250.

    PubMed  Google Scholar 

  23. Ferenci P, Lockwood A, Mullen KD, Tarter R, Weissenborn K, Blei AT et al. Hepatic encephalopathy - Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716–721.

    Article  PubMed  Google Scholar 

  24. Kim T, Murakami T, Sugihara E, Hori M, Wakasa K, Nakamura H. Hepatic nodular lesions associated with abnormal development of the portal vein. AJR Am J Roentgenol 2004; 183(5):1333–1338.

    PubMed  Google Scholar 

  25. Wanless IR, Lentz JS, Roberts EA. Partial nodular transformation of liver in an adult with persistent ductus venosus. Review with hypothesis on pathogenesis. Arch Pathol Lab Med 1985; 109(5):427–432.

    CAS  Google Scholar 

  26. Cheung KM, Lee CY, Wong CT, Chan AK. Congenital absence of portal vein presenting as hepatopulmonary syndrome. J Paediatr Child Health 2005; 41(1-2):72–75.

    Article  PubMed  CAS  Google Scholar 

  27. Garcia-Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009; 104(7):1802–1829.

    Article  PubMed  Google Scholar 

  28. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002; 19(2):140–148.

    Article  PubMed  CAS  Google Scholar 

  29. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 1999; 245(1):31–39.

    Article  PubMed  CAS  Google Scholar 

  30. Braverman IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 1990; 95(4):422–427.

    Article  PubMed  CAS  Google Scholar 

  31. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. New Eng J Med 1995; 333:918–924.

    Article  PubMed  CAS  Google Scholar 

  32. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994; 8(4):345–351.

    Article  PubMed  CAS  Google Scholar 

  33. McDonald MT, Papenberg KA, Ghosh S, Glatfelter AA, Biesecker BB, Helmbold EA et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet 1994; 6(2):197–204.

    Article  PubMed  CAS  Google Scholar 

  34. Shovlin CL, Hughes JM, Tuddenham EG, Temperley I, Perembelon YF, Scott J et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 1994; 6(2):205–209.

    Article  PubMed  CAS  Google Scholar 

  35. Lesca G, Olivieri C, Burnichon N, Pagella F, Carette MF, Gilbert-Dussardier B et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 2007; 9(1):14–22.

    Article  PubMed  Google Scholar 

  36. Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 1995; 5(1):21–28.

    Article  PubMed  CAS  Google Scholar 

  37. Vincent P, Plauchu H, Hazan J, Faure S, Weissenbach J, Godet J. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 1995; 4(5):945–949.

    Article  PubMed  CAS  Google Scholar 

  38. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363(9412):852–859.

    Article  PubMed  CAS  Google Scholar 

  39. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006; 43(2):97–110.

    Article  PubMed  CAS  Google Scholar 

  40. Cole SG, Begbie ME, Wallace GM, Shovlin CL. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005; 42(7):577–582.

    Article  PubMed  CAS  Google Scholar 

  41. Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 2006; 140(20):2155–2162.

    PubMed  Google Scholar 

  42. Lebrin F, Srun S, Raymond K, Martin S, van den BS, Freitas C et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010; 16(4):420–428.

    CAS  Google Scholar 

  43. Cloft HJ. Spontaneous regression of cerebral arteriovenous malformation in hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 2002; 23(6):1049–1050.

    PubMed  Google Scholar 

  44. Leung KM, Agid R, terBrugge K. Spontaneous regression of a cerebral arteriovenous malformation in a child with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg 2006; 105(5 Suppl):428–431.

    Google Scholar 

  45. Du R, Hashimoto T, Tihan T, Young WL, Perry V, Lawton MT. Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg 2007; 106(3):470–477.

    Google Scholar 

  46. Hashimoto M, Tate E, Nishii T, Watarai J, Shioya T, White RI. Angiography of hepatic vascular malformations associated with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 2003; 26(2):177–180.

    Article  PubMed  CAS  Google Scholar 

  47. Wheatley-Price P, Shovlin C, Chao D. Interferon for metastatic renal cell cancer causing regression of hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 2005; 39(4):344–345.

    Article  PubMed  CAS  Google Scholar 

  48. Massoud OI, Youssef WI, Mullen KD. Resolution of hereditary hemorrhagic telangiectasia and anemia with prolonged alpha-interferon therapy for chronic hepatitis C. J Clin Gastroenterol 2004; 38(4):377–379.

    Article  PubMed  Google Scholar 

  49. Flieger D, Hainke S, Fischbach W. Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab. Ann Hematol 2006; 85(9):631–632.

    Article  PubMed  Google Scholar 

  50. Mitchell A, Adams LA, MacQuillan G, Tibballs J, vanden Driesen R, Delriviere L. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl 2008; 14(2):210–213.

    Google Scholar 

  51. Akhurst RJ. Taking thalidomide out of rehab. Nat Med 2010; 16(4):370–372.

    Article  PubMed  CAS  Google Scholar 

  52. Garcia-Tsao G, Swanson KL. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: in search of predictors of significant disease. Hepatology 2008; 48(5):1377–1379.

    Article  PubMed  Google Scholar 

  53. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1986; 110:331–335.

    PubMed  CAS  Google Scholar 

  54. Sawabe M, Arai T, Esaki Y, Tsuru M, Fukazawa T, Takubo K. Three-dimensional organization of the hepatic microvasculature in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 2001; 125(9):1219–1223.

    PubMed  CAS  Google Scholar 

  55. Siddiki H, Doherty MG, Fletcher JG, Stanson AW, Vrtiska TJ, Hough DM et al. Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. Radiographics 2008; 28(1):171–184.

    Article  PubMed  Google Scholar 

  56. Buscarini E, Danesino C, Olivieri C, Lupinacci G, De Grazia F, Reduzzi L et al. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia – results of extensive screening. Ultraschall Med 2004; 25(5):348–355.

    Article  PubMed  CAS  Google Scholar 

  57. Ianora AA, Memeo M, Sabba C, Cirulli A, Rotondo A, Angelelli G. Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. Radiology 2004; 230(1):250–259.

    Article  PubMed  Google Scholar 

  58. Memeo M, Stabile Ianora AA, Scardapane A, Buonamico P, Sabba C, Angelelli G. Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 2004; 29(2):211–220.

    CAS  Google Scholar 

  59. Buonamico P, Suppressa P, Lenato GM, Pasculli G, D’Ovidio F, Memeo M et al. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study. J Hepatol 2008; 48(5):811–812.

    Article  PubMed  Google Scholar 

  60. Buscarini E, Danesino C, Plauchu H, de Fazio C, Olivieri C, Brambilla G et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 2004; 30(9):1089–1097.

    Article  PubMed  Google Scholar 

  61. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5(6):1194–1200.

    Article  PubMed  CAS  Google Scholar 

  62. Bioulac-Sage P, Laumonier H, Cubel G, Saric J, Balabaud C. Over-expression of glutamine synthase in focal nodular hyperplasia (part 1): Early stages in the formation support the hypothesis of a focal hyper-arterialisation with venous (portal and hepatic) and biliary damage. Comp Hepatol 2008; 7(1):2.

    Article  PubMed  Google Scholar 

  63. Odorico JS, Hakim MN, Becker YT, Van der Werf W, Musat A, Knechtle SJ et al. Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transplant Surg 1998; 4:483–490.

    Article  CAS  Google Scholar 

  64. Caselitz M, Wagner S, Chavan A, Gebel M, Bleck JS, Wu A et al. Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut 1998; 42:123–126.

    Article  PubMed  CAS  Google Scholar 

  65. Blewitt RW, Brown CM, Wyatt JI. The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia. Histopathology 2003; 42(3):265–269.

    Article  PubMed  CAS  Google Scholar 

  66. Buscarini E, Buscarini L, Danesino C, Piantanida M, Civardi G, Quaretti P et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screning in a large family. J Hepatol 1997; 26:111–118.

    Article  PubMed  CAS  Google Scholar 

  67. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Byrd R, Pollak JS et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 343:931–936.

    Article  PubMed  CAS  Google Scholar 

  68. Livneh A, Langevitz P, Morag B, Catania A, Pras M. Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telangiectasia. Southern Med J 1988; 81(8):1047–1049.

    Article  PubMed  CAS  Google Scholar 

  69. Khalid SK, Pershbacher J, Makan M, Barzilai B, Goodenberger D. Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia. Am J Med 2009; 122(8):779.

    Article  PubMed  Google Scholar 

  70. Gincul R, Lesca G, Gelas-Dore B, Rollin N, Barthelet M, Dupuis-Girod S et al. Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences. Hepatology 2008; 48(5):1570–1576.

    Article  PubMed  Google Scholar 

  71. Bauer T, Britton P, Lomas D, Wight DGD, Friend PJ, Alexander G.J.M. Liver transplantation for hepatic arteriovenous malformation in hereditary hemorrhagic telangiectasia. J Hepatol 1995; 22:586–590.

    Google Scholar 

  72. McInroy B, Zajko AB, Pinna AD. Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. AJR 1998; 170:413–415.

    PubMed  CAS  Google Scholar 

  73. Boillot O, Bianco F, Viale J-P, Mion F, Mechet I, Gille D et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology 1999; 116:187–192.

    Article  PubMed  CAS  Google Scholar 

  74. Hillert C, Broering DC, Gundlach M, Knoefel WT, Izbicki JR, Rogiers X. Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation. Liver Transpl 2001; 7(3):266–268.

    Article  PubMed  CAS  Google Scholar 

  75. Buscarini E, Plauchu H, Garcia-Tsao G., White RI, Jr., Sabba C, Miller F et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 2006; 26(9):1040–1046.

    Google Scholar 

  76. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD et al. International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. J Med Genet 2009.

    Google Scholar 

  77. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Kjeldsen AD et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genetics 2000; 91:65–66.

    Article  Google Scholar 

  78. Peck-Radosavljevic M, Zacher J, Meng YG, Pidlich J, Lipinski E, Langle F et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997; 27:127–131.

    Article  PubMed  CAS  Google Scholar 

  79. Caselitz M, Bahr MJ, Bleck JS, Chavan A, Manns MP, Wagner S et al. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). Hepatology 2003; 37(5):1139–1146.

    Article  PubMed  Google Scholar 

  80. Ravard G, Soyer P, Boudiaf M, Terem C, Abitbol M, Yeh JF et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr 2004; 28(4):488–495.

    Article  PubMed  Google Scholar 

  81. Wu JS, Saluja S, Garcia-Tsao G, Chong A, Henderson KJ, White RI. Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. AJR Am J Roentgenol 2006; 187:W399–405.

    Article  PubMed  Google Scholar 

  82. Buscarini E, Gebel M, Ocran K, Manfredi G, Del Vecchio BG, Stefanov R et al. Interobserver agreement in diagnosing liver involvement in hereditary hemorrhagic telangiectasia by Doppler ultrasound. Ultrasound Med Biol 2008.

    Google Scholar 

  83. Martini GA. The liver in hereditary haemorrhagic teleangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal. Gut 1978; 19:531–537.

    Article  PubMed  CAS  Google Scholar 

  84. Cooney T, Sweeney EC, Coll R, Greally M. “Pseudocirrhosis” in hereditary hemorrhagic telangiectasia. J Clin Pathol 1977; 30:1134–1141.

    Article  PubMed  CAS  Google Scholar 

  85. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001; 345:325–334.

    Article  PubMed  CAS  Google Scholar 

  86. Faughnan ME, Granton JT, Young LH. The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J 2009; 33(5):1186–1194.

    Article  PubMed  CAS  Google Scholar 

  87. Lin E, Stall L. Spectrum of biliary abnormalities in hepatic hereditary hemorrhagic telangiectasia: demonstration by multidetector computed tomography. Emerg Radiol 2007; 14(6):461–463.

    Article  PubMed  Google Scholar 

  88. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49(5):1729–1764.

    Article  PubMed  CAS  Google Scholar 

  89. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46(3):922–938.

    Article  PubMed  CAS  Google Scholar 

  90. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39(3):841–856.

    Article  PubMed  Google Scholar 

  91. Lee JY, Korzenik JR, DeMasi R, Lih-Brody L, White RI. Transjugular intrahepatic portosystemic shunts in patients with hereditary hemorrhagic telangiectasia: failure to palliate gastrointestinal bleeding. JVIR 1998; 9:994–997.

    Article  PubMed  CAS  Google Scholar 

  92. Chanson N, Carbonell N, Andreani T, Bellaiche G, Cluzel P, Serfaty L et al. TIPS in hereditary hemorrhagic telangiectasia: Never say never. J Hepatol 2008; 48(2):373–374.

    Article  PubMed  CAS  Google Scholar 

  93. Bourgeois N, Delcour C, Deviere J, Francois A, Lambert M, Cremer M et al. Osler-Weber-Rendu disease associated with hepatic involvement and high output heart failure. J Clin Gastroenterol 1990; 12(2):236–237.

    Article  PubMed  CAS  Google Scholar 

  94. Koscielny A, Willinek WA, Hirner A, Wolff M. Treatment of High Output Cardiac Failure by Flow-Adapted Hepatic Artery Banding (FHAB) in Patients with Hereditary Hemorrhagic Telangiectasia. J Gastrointest Surg 2007; %20.

    Google Scholar 

  95. Pfitzmann R, Heise M, Langrehr JM, Jonas S, Steinmuller T, Podrabsky P et al. Liver transplantation for treatment of intrahepatic Osler’s disease: first experiences. Transplantation 2001; 72(2):237–241.

    Article  PubMed  CAS  Google Scholar 

  96. Thevenot T, Vanlemmens C, Di M, V, Becker MC, Denue PO, Kantelip B et al. Liver transplantation for cardiac failure in patients with hereditary hemorrhagic telangiectasia. Liver Transpl 2005; 11(7):834–838.

    Google Scholar 

  97. Lerut J, Orlando G, Adam R, Sabba C, Pfitzmann R, Klempnauer J et al. Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry. Ann Surg 2006; 244(6):854–864.

    Article  PubMed  Google Scholar 

  98. Dupuis-Girod S, Chesnais AL, Ginon I, Dumortier J, Saurin JC, Finet G et al. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study. Liver Transpl 2010; 16(3):340–347.

    PubMed  Google Scholar 

  99. Garcia-Tsao G, Gish RG, Punch J. MELD Exception for Hereditary Hemorrhagic Telangiectasia. Liver Transpl 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guadalupe Garcia-Tsao .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer New York

About this chapter

Cite this chapter

Garcia-Tsao, G. (2011). Congenital Hepatic Vascular Malformations. In: DeLeve, L., Garcia-Tsao, G. (eds) Vascular Liver Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-8327-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8327-5_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-8326-8

  • Online ISBN: 978-1-4419-8327-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics